Medical Professional financing for your medical practice! Learn how to get funding with medical practice financing.
Call: 904-551-6090
Over the years we have been able to finance a lot of start up medical practice units with excellent services. The great repayments rates that are stated by the company will give you the chance to order your finances well. All the low repayment rates are aimed at financing your financial program by virtue that it was specifically designed to help fresh medical doctors who are in need of financial assistance to start up their medical practice. With confidence, you should make our company your financial source as we are dedicated to make your dreams a reality.
Read The Interesting Snippets Below For Exciting Health-Care News!
NEW YORK, Aug 7 (Reuters) – Generic drugmaker Perrigo Co is expected to launch $3.25 billion in credit facilities backing its $8.6 billion acquisition of Irish biotechnology firm Elan to general syndication next week, sources told Thomson Reuters LPC.
Continue Reading On http://www.reuters.com »
NEW YORK (Reuters Health) – Elderly people with high blood sugar – but not high enough to be diabetic – face a slightly greater risk of developing dementia, according to a new study of over 2,000 volunteers.
Continue Reading On http://www.reuters.com/healthNews »
Aug 7 (Reuters) – Array Biopharma said it would cut 20 percent of its workforce as Amgen Inc plans to end an agreement to develop and market Array’s drug to treat Type 2 diabetes.
Continue Reading On http://www.reuters.com »
(Reuters) – Array Biopharma said it would cut 20 percent of its workforce as Amgen Inc plans to end an agreement to develop and market Array’s drug to treat Type 2 diabetes.
Continue Reading On http://www.reuters.com/healthNews »
ZURICH (Reuters) – While a wave of stock market enthusiasm in the United States for biotech company flotations has yet to cross the Atlantic, venture capital appetite for promising European companies is returning.
Continue Reading On http://www.reuters.com/healthNews »
Exclusive: TPG explores $3 billion sale of specialty drugmaker Aptalis
– http://www.reuters.com/healthNews
NEW YORK (Reuters) – TPG Capital LP has been exploring a sale of Aptalis Pharma, a specialty drugmaker it has owned since 2008 and values at more than $3 billion, four people familiar with the matter said on Wednesday.
Continue Reading On http://www.reuters.com/healthNews »
Medical Practice Loans!
Array says Amgen ends agreement, to cut 20 percent jobs + MORE No down payment medical, dental and healthcare provider practice financing here! 08/07/2013
No comments:
Post a Comment